Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability

<p>Abstract</p> <p>Background</p> <p>The recent H1N1 influenza pandemic illustrated the shortcomings of the vaccine manufacturing process. The A/California/07/2009 H1N1 pandemic influenza vaccine or A(H1N1)pdm09 was available late and in short supply as a result of dela...

Full description

Bibliographic Details
Main Authors: Feshchenko Elena, Rhodes David G, Felberbaum Rachael, McPherson Clifton, Rininger Joseph A, Post Penny, Cox Manon MJ
Format: Article
Language:English
Published: BMC 2012-10-01
Series:BMC Biotechnology
Subjects:
Recombinant hemagglutinin
Influenza pandemic vaccine
H1N1
Baculovirus expression vector system (BEVS)
Flublok
A(H1N1)pdm09
Online Access:http://www.biomedcentral.com/1472-6750/12/77

Internet

http://www.biomedcentral.com/1472-6750/12/77

Similar Items